16 май 2018 г. - FDA approved Lucemyra (lofexidine hydrochloride), the first non-opioid treatment for the mitigation of withdrawal symptoms associated with abrupt discontinuation of opioids.
Добавлено на ленту времени:
Дата:
16 май 2018 г.
Сейчас
~ 7 гг и 5 мес назад